<DOC>
	<DOCNO>NCT01197287</DOCNO>
	<brief_summary>There three element study : - Part A : Single dose escalation healthy subject . 6 dose level QAK423 plan healthy volunteer . - Part B : Single dose escalation patient mild/moderate COPD . 3 dose level QAK423 plan COPD patient . - Part C : Titrated repeat dose maximum 14 day mild/moderate COPD patient . Repeat dose plan COPD patient .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics QAK423A Healthy Volunteers Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Part A : Healthy , male subject age 1855 year age able provide write informed consent prior study participation determine good health past medical history , physical examination , ECG , laboratory test urinalysis . Parts B C : Male female ( post menopausal surgically sterilize ) patient COPD , age 4075 year , smoke history least 10 pack year ( i.e . smoker exsmokers ) . Diagnosis mild moderate COPD , accord GOLD guideline . Postbronchodilator FEV1 screen 5080 % predict . No COPD exacerbation within 3 month prior dose , concomitant lung disease asthma , requirement long term oxygen treatment history lung reduction surgery . No medical condition may jeopardize subject participation study Weigh le 100 kg Use prescription drug overthecounter ( OTC ) medication within 2 week prior dose . History acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat treat ) . Participation clinical investigation within 4 week prior dose longer required local regulation . History clinically significant drug allergy . A known hypersensitivity study drug drug similar study drug . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Chronic obstructive pulmonary disease</keyword>
</DOC>